Celltrion Pharm, Inc.
KOE: 068760.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yoo Young-Ho
- Employees
- 888
- Headquarters
- Cheongju, South Korea
- IPO year
- 2006
- Market cap
- ₩2.4T
- Website
- https://www.celltrionph.com
Loading 068760…
Loading profile data…Frequently asked questions about 068760
What does Celltrion Pharm, Inc. (068760.KQ) do?
Celltrion Pharm, Inc., a pharmaceutical company, develops and sells biosimilars and over-the-counter drugs in South Korea. The company offers hepatotonic, anti-inflammatory, antihistamine, respiratory apparatus, circulary system, digestive and stomachic, hormone/metabolic disease, antibiotic/antimycotic, nutrientia and tonic, immunology, oncolog...
Where does 068760.KQ trade?
Celltrion Pharm, Inc. (068760.KQ) trades on the KOSDAQ.
What sector is 068760.KQ in?
Celltrion Pharm, Inc. (068760.KQ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Celltrion Pharm, Inc.?
Yoo Young-Ho is the chief executive officer of Celltrion Pharm, Inc. (068760.KQ).
Where is Celltrion Pharm, Inc. headquartered?
Celltrion Pharm, Inc. is headquartered in South Korea.
Does 068760.KQ pay a dividend?
Yes — Celltrion Pharm, Inc. (068760.KQ) paid a trailing twelve-month dividend of KRW 200.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 068760.KQ go public?
Celltrion Pharm, Inc. (068760.KQ) completed its initial public offering in 2006.